Should we sequence everyone's genome? No

BMJ (Online)

Volumn 346, Issue 7909, 2013, Pages

  Flinter, Frances ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DNA DAMAGE; DNA SEQUENCE; EXOME; FAMILIAL DISEASE; GENE SEQUENCE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUNTINGTON CHOREA; NEOPLASM; NOTE; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE; RISK FACTOR; SHORT TANDEM REPEAT; VALIDITY; Y CHROMOSOME; GENETICS; HUMAN GENOME;

GENOME, HUMAN; HUMANS;

MLCS; MLOWN;

EID: 84878342197     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f3132     Document Type: Note

References (10)

1. Wright C, Burton H, Hall A, Moorthie S, Pokorska-Bocci A, Sagoo G, et al. Next steps in the sequence. The implications of whole genome sequencing for health in the UK. PHG Foundation, 2011.
2. Gullapalli RR, Desai KV, Santana-Santos L, Kant JA, Becich MJ. Next generation sequencing in clinical medicine: challenges and lessons for pathology and biomedical informatics. J Pathol Inform 2012;3:40.
3. Rabbani B, Mahdieh N, Hosomichi K, Nakaoka H, Inoue I. Next-generation sequencing: impact of exome sequencing in charaterizing Mendelian disorders. J Hum Genet 2012;57:621-32.
4. Hawkes N. Cameron announces £100m for "unlocking the power of DNA data." BMJ 2012.345:e8413.
5. PHG Foundation. Strategy for life sciences: implications for population health. www.phgfoundation.org/file/13189.
6. Xue Y, Chen Y, Ayub Q, Huang N, Ball EV, Mort M, et al. Deleterious and disease allele prevalence in healthy individuals: insights from current predication, mutation databases and population-scale resequencing. Am J Hum Genet 2012;91:1022-32.
7. PHG Foundation. Managing incidental and pertinent findings from WGS in the 100 000 Genome Project. www.phgfoundation.org/file/13772.
8. Biesecker LG, Burke W, Kohane I, Plan SE, Zimmern R. Next-generation sequencing in the clinic: are we ready? Nature 2012;13:818-24.
9. Groisman IJ, Mathieu G, Godard B. Use of next generation sequencing technologies in research and beyond: are participants with mental health disorders fully protected? BMC Med Ethics 2012;13:36.
10. Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y. Identifying personal genomes by surname inference. Science 2013;339:321-4.